|
|
||||||||
a Division of Thoracic and Foregut Surgery, Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
b Division of Pulmonary Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
c Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, Pennsylvania
Accepted for publication November 30, 2011.
* Address correspondence to Dr Schuchert, Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Shadyside Medical Building, Ste 715, 5200 Centre Ave, Pittsburgh, PA 15232 (Email: schuchertmj{at}upmc.edu).
Presented at the Forty-seventh Annual Meeting of The Society of Thoracic Surgeons, San Diego, CA, Jan 31–Feb 2, 2011.
Background: Anatomic segmentectomy is a versatile sublobar resection approach that can be both diagnostic and therapeutic in the setting of the indeterminate pulmonary nodule (IPN), metastasectomy, as well as small, peripheral cancers. We analyzed the clinical indications and perioperative outcomes after anatomic segmentectomy and explored its utility in the diagnosis and treatment of IPNs and small stage IA lung cancers.
Methods: This study is a retrospective review of 785 consecutive patients undergoing anatomic segmentectomy from 2002 to 2010. Primary outcome variables include perioperative course, morbidity, mortality, recurrence patterns, and survival.
Results: Surgical indications included IPN (62.4%), known lung cancer (27.6%), suspected metastasis (4.1%), bullous disease (3.7%), or other (2.2%). Video-assisted thoracic surgery was employed in 468 (59.6%) and open thoracotomy in 317 (40.4%) patients. Median length of stay was 6 days. Overall complication rate was 34.9%. Thirty-day mortality was 1.1%. Among 490 patients with an IPN, 381 (77.7%) were found to have lung cancer, 41 (8.4%) metastatic cancer, and 68 (13.9%) benign disease. Among patients with pathologic stage IA lung cancer, there was no difference in recurrence rates (14.5% vs 13.9%) or 5-year freedom from recurrence estimates (78% in each group, p = 0.738) when comparing segmentectomy and lobectomy.
Conclusions: Anatomic segmentectomy provides acceptable morbidity and mortality when approaching the IPN. Cancer is identified in 86% of lesions. Complete surgical resection can be achieved with generous parenchymal margins and thorough nodal staging for small, peripheral stage IA non-small cell lung cancer. The use of anatomic segmentectomy should be considered in this era of competing image-guided diagnostic and therapeutic approaches to peripheral lung pathology.
This article has been cited by other articles:
![]() |
H. Kato, H. Oizumi, T. Inoue, E. Oba, K. Nakamura, J. Hayashi, H. Watarai, T. Yasumoto, and M. Sadahiro Port-access thoracoscopic anatomical lung subsegmentectomy Interact CardioVasc Thorac Surg, June 1, 2013; 16(6): 824 - 829. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zuin, L. G. Andriolo, G. Marulli, M. Schiavon, S. Nicotra, F. Calabrese, P. Romanello, and F. Rea Is lobectomy really more effective than sublobar resection in the surgical treatment of second primary lung cancer? Eur J Cardiothorac Surg, May 8, 2013; (2013) ezt219v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Liao, Q. Pu, J. Mei, L. Ma, and L. Liu Value of Video-Assisted Thoracic Surgery Core Needle Biopsy in the Selection of Surgical Approaches for Indeterminate Pulmonary Nodules Ann. Thorac. Surg., February 1, 2013; 95(2): 772 - 772. [Full Text] [PDF] |
||||
![]() |
M. J. Schuchert and R. J. Landreneau Reply Ann. Thorac. Surg., February 1, 2013; 95(2): 772 - 773. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |